CIMZIA (Certolizumab Pegol) is effective in the treatment of Crohn's Disease patients with open fistulas

被引：0
|
作者：
Schreiber, S. [1 ]
Lawranc, I [2 ]
Thomsen, O. [3 ]
Hanauer, S. [4 ]
Bloomfield, R. [5 ]
Sandborn, W. [6 ]
机构：
[1] Univ Kiel, Hosp Gen Internal Med, Kiel, Germany
[2] Univ Western Australia, Fremantle Hosp, Fremantle, WA, Australia
[3] Univ Copenhagen, Herlev Hosp, DK-2730 Herlev, Denmark
[4] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[5] UCB Pharma, Slough, Berks, England
[6] Mayo Clin, Rochester, MN USA
来源：
INFLAMMATORY BOWEL DISEASES | 2008年 / 14卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [21] Maintenance therapy with certolizumab pegol for Crohn's disease
    Schreiber, Stefan
    Khaliq-Kareemi, Mani
    Lawrance, Ian C.
    Thomsen, Ole Ostergaard
    Hanauer, Stephen B.
    McColm, Juliet
    Bloomfield, Ralph
    Sandborn, William J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 239 - 250
  • [22] Certolizumab pegol for induction of remission in Crohn's disease
    Yamazaki, Hajime
    So, Ryuhei
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Shinzaki, Shinichiro
    Matsuura, Minoru
    Okabayashi, Shinji
    Kataoka, Yuki
    Tsujimoto, Yasushi
    Furukawa, Toshi A.
    Watanabe, Norio
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (08):
  • [23] Certolizumab Pegol for Active Crohn's Disease Reply
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (03) : 327 - 328
  • [24] Assessment of the Efficacy of Certolizumab Pegol in the Maintenance of Response for the Treatment of Crohn's Disease
    Lee, Scott D.
    Ko, Cynthia W.
    Wahbeh, Ghassan
    Cullinan, Cory
    Etter, Scott
    Sinanan, Mika N.
    Wheat, Chelle
    GASTROENTEROLOGY, 2011, 140 (05) : S282 - S282
  • [25] Certolizumab pegol for the treatment of Crohn's disease is approved now for a using in the USA
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2008, 46 (08): : 855 - 855
  • [26] Certolizumab pegol (CDP870) for treatment of Crohn's disease - Reply
    Schreiber, S
    GASTROENTEROLOGY, 2006, 130 (01) : 286 - 286
  • [27] HEALTHCARE SERVICE UTILIZATION AND COSTS OF CERTOLIZUMAB PEGOL VERSUS INFLIXIMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE
    Tkacz, Joseph
    Lee, Edward
    Low, Robert
    Stark, Jeffrey
    Yassine, Mohamed
    Brady, Brenna L.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S15 - S15
  • [28] HEALTHCARE SERVICE UTILIZATION AND COSTS OF CERTOLIZUMAB PEGOL VERSUS INFLIXIMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE
    Tkacz, Joseph
    Lee, Edward
    Low, Robert
    Stark, Jeffrey
    Yassine, Mohamed
    Brady, Brenna L.
    GASTROENTEROLOGY, 2018, 154 (01) : S22 - S22
  • [29] Severe Crohn's disease symptoms are relieved by certolizumab pegol
    Feagan, Brian G.
    Coteur, Geoffroy
    Keininger, Doroth L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S471 - S471
  • [30] Certolizumab pegol: A guide to its use in Crohn's disease
    不详
    Drugs & Therapy Perspectives, 2007, 23 (11) : 5 - 8
12345